
jumped to a high of 454,000 in August 2021, from about 57,000 in January 2020, according to healthcare data firm IQVIA. The number of monthly ivermectin prescriptions in the U.S. During the pandemic, there has been a surge of demand for ivermectin, a drug commonly used to treat parasites in people who live in regions of South America and Africa, as well as in livestock. It’s just one of several retractions and withdrawals of studies pointing to ivermectin as a viable COVID-19 treatment, and the impact of this kind of fraudulent research is still reverberating. Within 24 hours, Lawrence got a response from the editor, and the website withdrew the paper in mid-July. Lawrence would go on to contact Research Square, the website that published the paper, which had not been peer-reviewed. “And I went out of my room to tell everyone, you know, my housemates, being like, ‘Oh, my God, you will not believe what I’ve just found.’ ” Other patients included in the trial had been hospitalized before the study began. Some of the patient data had been duplicated. The number of deaths cited in the paper did not match the number of deaths in the database.

He made a few attempts, and then he tried “1-2-3-4.” It worked.įrom there, Lawrence discovered that the issues went far beyond plagiarism.


Lawrence paid $10.80 for a subscription to reactivate the link, which had expired in January 2021, only to find the file required a password. He clicked through to a file-sharing website, where the study’s dataset was housed. Lawrence, who is in his mid-20s and studying biomedical science, kept researching online. “Although there a lot of parts of the paper that were badly written, there are also a few sentences which had perfect grammar, perfect everything, and could have been plucked right out of another scientific paper. “Suddenly, I started noticing something,” Lawrence said.
